Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

AP-1: a double-edged sword in tumorigenesis.

Eferl R, Wagner EF.

Nat Rev Cancer. 2003 Nov;3(11):859-68. Review. No abstract available.

PMID:
14668816
3.

Inhibition of prolactin (PRL)-induced proliferative signals in breast cancer cells by a molecular mimic of phosphorylated PRL, S179D-PRL.

Schroeder MD, Brockman JL, Walker AM, Schuler LA.

Endocrinology. 2003 Dec;144(12):5300-7. Epub 2003 Sep 11.

PMID:
12970160
4.
5.

Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways.

Acosta JJ, Muñoz RM, González L, Subtil-Rodríguez A, Dominguez-Caceres MA, García-Martínez JM, Calcabrini A, Lazaro-Trueba I, Martín-Pérez J.

Mol Endocrinol. 2003 Nov;17(11):2268-82. Epub 2003 Aug 7.

PMID:
12907754
6.

FosB is highly expressed in normal mammary epithelia, but down-regulated in poorly differentiated breast carcinomas.

Milde-Langosch K, Kappes H, Riethdorf S, Löning T, Bamberger AM.

Breast Cancer Res Treat. 2003 Feb;77(3):265-75.

PMID:
12602926
7.

The role of prolactin in mammary carcinoma.

Clevenger CV, Furth PA, Hankinson SE, Schuler LA.

Endocr Rev. 2003 Feb;24(1):1-27. Review.

8.

c-Jun N-terminal kinase activation of activator protein-1 underlies homologous regulation of the gonadotropin-releasing hormone receptor gene in alpha T3-1 cells.

Ellsworth BS, White BR, Burns AT, Cherrington BD, Otis AM, Clay CM.

Endocrinology. 2003 Mar;144(3):839-49.

PMID:
12586760
9.

p38 isoforms have opposite effects on AP-1-dependent transcription through regulation of c-Jun. The determinant roles of the isoforms in the p38 MAPK signal specificity.

Pramanik R, Qi X, Borowicz S, Choubey D, Schultz RM, Han J, Chen G.

J Biol Chem. 2003 Feb 14;278(7):4831-9. Epub 2002 Dec 9.

10.

The association of breast mitogens with mammographic densities.

Boyd NF, Stone J, Martin LJ, Jong R, Fishell E, Yaffe M, Hammond G, Minkin S.

Br J Cancer. 2002 Oct 7;87(8):876-82.

11.

Molecular interpretation of ERK signal duration by immediate early gene products.

Murphy LO, Smith S, Chen RH, Fingar DC, Blenis J.

Nat Cell Biol. 2002 Aug;4(8):556-64.

PMID:
12134156
12.

Cell cycle promoting activity of JunB through cyclin A activation.

Andrecht S, Kolbus A, Hartenstein B, Angel P, Schorpp-Kistner M.

J Biol Chem. 2002 Sep 27;277(39):35961-8. Epub 2002 Jul 16.

13.

Promoter specificity and biological activity of tethered AP-1 dimers.

Bakiri L, Matsuo K, Wisniewska M, Wagner EF, Yaniv M.

Mol Cell Biol. 2002 Jul;22(13):4952-64.

14.
15.

AP-1 as a regulator of cell life and death.

Shaulian E, Karin M.

Nat Cell Biol. 2002 May;4(5):E131-6. Review.

PMID:
11988758
16.

PRL activates the cyclin D1 promoter via the Jak2/Stat pathway.

Brockman JL, Schroeder MD, Schuler LA.

Mol Endocrinol. 2002 Apr;16(4):774-84.

PMID:
11923474
17.

PRL modulates cell cycle regulators in mammary tumor epithelial cells.

Schroeder MD, Symowicz J, Schuler LA.

Mol Endocrinol. 2002 Jan;16(1):45-57.

PMID:
11773438
18.

Signaling pathways in mammary gland development.

Hennighausen L, Robinson GW.

Dev Cell. 2001 Oct;1(4):467-75. Review.

19.

Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression.

Toft DJ, Rosenberg SB, Bergers G, Volpert O, Linzer DI.

Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13055-9. Epub 2001 Oct 23.

20.

Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway.

Mody N, Leitch J, Armstrong C, Dixon J, Cohen P.

FEBS Lett. 2001 Jul 27;502(1-2):21-4.

Items per page

Supplemental Content

Write to the Help Desk